First human test: scientists probe safety of new capsule
NCT ID NCT07372703
Summary
This is a first-in-human study to check the safety and see how the body absorbs and eliminates a new capsule called VV913. It will involve 56 healthy male volunteers who will receive a single dose of either the capsule or a placebo. The main goal is to understand how safe the capsule is and how it moves through the body at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.